Bioactive dietary peptides and amino acids in inflammatory bowel disease. - Test2 - elhamkhani - TriplyDB

Bioactive dietary peptides and amino acids in inflammatory bowel disease.

Bioactive dietary peptides and amino acids in inflammatory bowel disease.

http://www.wikidata.org/entity/Q38287022

about

Bioactive Molecules Released in Food by Lactic Acid Bacteria: Encrypted Peptides and Biogenic Amines Water dynamics of Ser-His-Glu-Cys-Asn powder and effects of moisture absorption on its chemical properties.Potential role of nutraceutical compounds in inflammatory bowel disease Dietary Protein and Amino Acid Supplementation in Inflammatory Bowel Disease Course: What Impact on the Colonic Mucosa?Investigation of mitigating effect of colon-specific prodrugs of boswellic acid on 2,4,6-trinitrobenzene sulfonic acid-induced colitis in Wistar rats: Design, kinetics and biological evaluation.Roles of Dietary Amino Acids and Their Metabolites in Pathogenesis of Inflammatory Bowel Disease.Anti-inflammatory effects of Dioscorea alata L. anthocyanins in a TNBS-induced colitis model.Pathomechanisms of Oxidative Stress in Inflammatory Bowel Disease and Potential Antioxidant Therapies.Collagen peptides ameliorate intestinal epithelial barrier dysfunction in immunostimulatory Caco-2 cell monolayers via enhancing tight junctions.Protective effects of β-casofensin, a bioactive peptide from bovine β-casein, against indomethacin-induced intestinal lesions in rats.

P2860

Q26745047-1308D2EC-D7DE-4BCE-9507-C75FF23442A8 Q31144498-C2997E67-762C-46DB-B2D8-BC2E0A6C4015 Q33572633-A787237A-3A49-4D7E-894F-EC2A46D78E11 Q36320785-6FB03B44-2EA9-44E3-B990-E37E465F616F Q37662616-7308B027-574C-4CDC-B440-F4DA6115C026 Q37723673-2CB390B8-C5A4-465D-8FC6-6AC862309560 Q38942174-2554CC88-D3A4-4D24-B647-065DED1EE442 Q39458419-24600C92-5A76-4ADC-A7C6-0D005899B5FB Q51013505-DCFD7DB8-5357-46AE-8E88-45E24A48FE6C Q53224425-68127FF4-61CD-4BCA-93FE-ADF83E4C9D54

P2860

Bioactive dietary peptides and amino acids in inflammatory bowel disease.

http://www.wikidata.org/entity/Q38287022

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Bioactive dietary peptides and amino acids in inflammatory bowel disease.

@en

type

label

Bioactive dietary peptides and amino acids in inflammatory bowel disease.

@en

prefLabel

Bioactive dietary peptides and amino acids in inflammatory bowel disease.

@en

P1433

Q38287022-9C4434A7-957D-4EE9-83F8-243E3AC232AD

P1476

Q38287022-6E9A62B6-674C-4FF5-9C9F-2A743698C75B

P2093

Q38287022-645650BA-60AF-4210-91A2-F1DB57C0C94B

Q38287022-6A364247-D50B-4F1B-BBCA-899AA1AB3852

Q38287022-9F7F6D16-C2DE-4FB4-B3A1-04404A6DED5C

Q38287022-A81BF738-C02B-4579-A5E6-5AFAF712DCF5

P2860

Q38287022-00C8A701-7995-4751-B213-490623CF0C6A

Q38287022-075AF112-428F-4797-8726-FA6A72DAF7EA

Q38287022-12258546-F911-4200-87E0-01ABF9605C0B

Q38287022-123EE20F-E475-4F81-92D0-E206520BAE54

Q38287022-192066EF-1EA5-46C5-9A01-F652F8E8E670

Q38287022-1CA38977-9DCB-4FFF-91A0-6A959A6FC71A

Q38287022-234472B6-5F15-4527-AE6B-4EDC3F14D0AA

Q38287022-2391769D-3022-4912-97A1-C3AC1A65ADAB

Q38287022-24594D8C-9EE0-41C4-96E0-E4DC3BF44A3E

Q38287022-2586EE4A-8FA2-42CD-81C6-93C797EE28E6

P2888

Q38287022-9CE8E2A1-599D-4D15-ABCB-233246E0144B

P304

Q38287022-A7DD603D-59CC-49FF-8284-43B5E4F9FD17

P31

Q38287022-3E2E3511-5F46-43CA-A3D7-126D6F241843

P356

Q38287022-B821415A-A815-44FF-9FFE-968BE209705E

P433

Q38287022-C1240860-E54C-4FB9-8F5B-923016E20C17

P478

Q38287022-B3AEE29E-AA93-4C7B-A9CA-C2AFF0B83B6B

P577

Q38287022-F0D7CAF1-CCAC-4E35-A5A3-E663D488D5BC

P698

Q38287022-42E47797-1A67-447E-820F-D13E68E7B454

P921

Q38287022-15F24305-26F1-48C7-9076-5FBA42B3FECD

P356

S00726-014-1886-9

P1433

P1476

Bioactive dietary peptides and amino acids in inflammatory bowel disease.

@en

P2093

Chien-An A Hu

http://www.w3.org/2001/XMLSchema#string

Hua Zhang

http://www.w3.org/2001/XMLSchema#string

Jennifer Kovacs-Nolan

http://www.w3.org/2001/XMLSchema#string

Yoshinori Mine

http://www.w3.org/2001/XMLSchema#string

P2860

A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway

Inflammatory bowel disease: clinical aspects and established and evolving therapies

The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway

Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis

TAK1 is a ubiquitin-dependent kinase of MKK and IKK

Association of beta-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling

The hairpin-type tail-anchored SNARE syntaxin 17 targets to autophagosomes for fusion with endosomes/lysosomes

CaSR stimulates secretion of Wnt5a from colonic myofibroblasts to stimulate CDX2 and sucrase-isomaltase using Ror2 on intestinal epithelia

Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-kappaB pathways

TAK1 is a master regulator of epidermal homeostasis involving skin inflammation and apoptosis

P2888

s00726-014-1886-9

P304

2127-2141

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00726-014-1886-9

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25501277

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases